Anthem

Anthem (now Elevance Health) is one of the largest BCBS-affiliated insurers, operating Blue Cross and Blue Shield plans in 14 states. Anthem uses clinical UM guidelines and drug-specific prior authorization criteria. Their IngenioRx pharmacy benefit manager handles pharmacy benefit drugs.

Common Denial Patterns

• •IngenioRx pharmacy criteria not met — separate from medical benefit criteria
• •Step therapy requirements for biologic drugs not completed
• •Clinical UM guideline criteria not met for the specific indication
• •Site-of-care management program requires alternative infusion setting
• •Prior authorization not obtained before service was rendered

Step Therapy Approach

Anthem's step therapy follows clinical UM guidelines that are generally aligned with major clinical guidelines but include cost-effectiveness considerations. IngenioRx manages pharmacy benefit step therapy separately. Anthem has been aggressive with biosimilar-first requirements for TNF inhibitors and other biologic classes.

Appeal Process

Internal appeals within 180 days of denial. Anthem accepts appeals via provider portal, fax, or mail. Peer-to-peer reviews available for medical necessity disputes. External review through state insurance department after internal appeal exhaustion. Timeline varies by state.

Tips for Appealing Anthem Denials

1. 1.Check if the drug is managed by IngenioRx (pharmacy) or Anthem medical — different appeal pathways
2. 2.Anthem's clinical UM guidelines are available to providers on their portal — review before PA submission
3. 3.For site-of-care redirection, document medical necessity for the current infusion setting
4. 4.Anthem operates as different BCBS affiliates in each state — verify the specific state plan
5. 5.Peer-to-peer reviews with Anthem medical directors are generally available within 24–48 hours